Mengdie Cao

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Cancer-Associated Fibroblast-Derived Sphingosine-1-Phosphate Activates a MALL-SDC4 Axis to Facilitate Perineural Invasion in Pancreatic Cancer.

Cancer-Associated Fibroblast-Derived Sphingosine-1-Phosphate Activates a MALL-SDC4 Axis to Facilitate Perineural Invasion in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 03, 2025

CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK.

CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK.

Journal: Oncogenesis

Published: August 17, 2025

Oncofetal dual‑specificity phosphatase 9 drives stem-like properties through ERK1/2-PPARG-SCD axis-mediated lipid metabolism in hepatocellular carcinoma.

Oncofetal dual‑specificity phosphatase 9 drives stem-like properties through ERK1/2-PPARG-SCD axis-mediated lipid metabolism in hepatocellular carcinoma.

Journal: Clinical and translational medicine

Published: August 11, 2025

Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer.

Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer.

Journal: Journal for immunotherapy of cancer

Published: May 29, 2025

The cancer-associated fibroblast facilitates YAP liquid-liquid phase separation to promote cancer cell stemness in HCC.

The cancer-associated fibroblast facilitates YAP liquid-liquid phase separation to promote cancer cell stemness in HCC.

Journal: Cell communication and signaling : CCS

Published: April 08, 2025

Senescent fibroblasts secrete CTHRC1 to promote cancer stemness in hepatocellular carcinoma.

Senescent fibroblasts secrete CTHRC1 to promote cancer stemness in hepatocellular carcinoma.

Journal: Cell communication and signaling : CCS

Published: April 02, 2025

PPY-Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer.

PPY-Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 22, 2024

Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer.

Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer.

Journal: Carcinogenesis

Published: July 16, 2024

Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer.

Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer.

Journal: iScience

Published: May 28, 2024

Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells.

Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells.

Journal: Cell death & disease

Published: November 07, 2023

Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma.

Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma.

Journal: Computers in biology and medicine

Published: September 20, 2023

Targeting lysosomes in human disease: from basic research to clinical applications.

Targeting lysosomes in human disease: from basic research to clinical applications.

Journal: Signal transduction and targeted therapy

Published: June 10, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026